香港, 2024年10月21日 - (亞太商訊 via SeaPRwire.com) - 隨著全球對可持續發展的重視，香港政府公佈《香港氣候行動藍圖 2050》，聯交所先後修訂，並將於2025年1月1日實施《ESG守則》，旨在加強上巿公司的環境管治及氣候信息透明度。在這一背景下，企業社會責任（CSR）及環境、社會及治理（ESG）已成為企業發展的重要基石，尤其是在香港的建築行業中，許多企業正積極推動這些努力，以展現對可持續未來的堅定承諾。首先，在職業健康與安全方面，許多公司始終將僱員的安全放在首位。例如，香港主板上市的建築公司正利控股有限公司（3728.HK），正在通過各種舉措推動企業社會責任和可持續發展。正利控股本年度參加了由香港中華廠商聯合會主辦的「ESG 約章」行動，獲得了第三方權威機構的認可。此舉旨在鞏固其在推廣和實踐ESG方面的領導地位。正利還承諾在未來降低工程及辦公室的能源消耗，並大力推動辦公室無紙化及內部環保政策。這不僅增強了企業的內部能力，還能在環保意識不斷提升的市場中贏得競爭優勢，推動企業的長期可持續發展。在工地場所，正利控股致力於提供安全的工作環境，並在建築工地定期進行應急演練。這不僅是企業的責任，更是對員工生命安全的尊重。此外，公司還重視增強僱員技能，培養未來的領袖。根據該集團年度報告的數據，僱員的培訓總時數達98.5小時，參訓比例高達約六成。這樣的培訓不僅提升了員工的專業技能，更讓員工意識到自身在社會環境中的重要角色。因為員工不僅是企業的生產力，更是環境保護和社會責任的參與者。某些公司在這方面的培訓體系，將員工的發展與企業的可持續發展目標緊密聯繫在一起，從而達到雙贏的效果。正利控股在推廣綠色建築技術方面也不遺餘力，公司要求所有員工在施工過程中嚴格遵守環保標準。例如，正利控股提倡使用可回收的建築材料，並在施工過程中最大限度地減少廢棄物產生。此外，該公司還積極推廣節能減排措施，如使用節能燈具和電動設備，以降低能源消耗。除了職業安全和技能培訓，企業在員工ESG方面還有其他舉措。例如，許多公司支持教育、醫療和文化等公益事業，並鼓勵員工參與社區服務。根據正利控股的年報數據，該公司在2023-2024財年向多個公益機構捐贈超過150萬港元，並有超過60名員工參與社區服務，這些行動彰顯了企業的社會參與。總體而言，對於環境及社會的探索之路，不僅僅是企業的責任，更是企業對員工的尊重和賦能。通過一系列的舉措，企業讓員工成為ESG的參與者，正利控股將企業的發展與員工的成長緊密聯繫在一起。這不僅是企業社會責任的體現，更是可持續發展的基石。 Copyright 2024 亞太商訊 via SeaPRwire.com.

Luxembourg, Oct 16, 2024 - (ACN Newswire via SeaPRwire.com) - Moolec Science SA (NASDAQ:MLEC) ("the Company"), a leader in Molecular Farming technology, announced today that the U.S. Department of Agriculture's ("USDA") Animal and Plant Health Inspection Service ("APHIS") has completed its Regulatory Status Review ("RSR") for the Company's genetically engineered ("GE") peas which produce iron through bovine meat proteins. This is the third regulatory clearance from USDA-APHIS achieved by Moolec in an 18-month window, alongside its genetically engineered safflower and soybean for GLASO™ and Piggy Sooy™ products, respectively. Access the official USDA-APHIS publication here."With USDA approval for our GE pea, Moolec has now secured regulatory clearance for all of our key crops in the US: safflower, soybean, and pea," said Gastón Paladini, CEO and Co-Founder of Moolec. "We are proud to be the only Molecular Farming company with three US regulatory approvals and a major commercial contract. This milestone underscores our leadership in the landscape with tangible, science-backed results."Moolec's genetically engineered peas produce high yields of bovine myoglobin, a protein that boosts iron content, making it an ideal alternative for consumers seeking plant-based sources of iron. This product has the potential to revolutionize both the food ingredient market and the $65 billion pea industry by offering a nutritious, iron-rich alternative to traditional meat products.Amit Dhingra, Chief Science Officer for the Company, stated, "The USDA-APHIS Regulatory Status Review for pea marks a significant milestone for Moolec. As the first review for GE pea, it represents a historic development. It validates Moolec's strategic approach and exemplifies our commitment advancing sustainable food production through science and innovation. This approval is a critical step toward enhancing global food supply and meeting the growing demand for innovative, nutritious food solutions for the world."This approval not only showcases Moolec's innovation in Molecular Farming but also highlights the company's commitment to meeting the highest regulatory and safety standards. Moolec has also developed an Identity Preservation Program to ensure sustainable farming practices, promote stewardship for its crops and product quality for partners, clients and consumers alike.According to USDA-APHIS regulation found at 7 CFR part 340, developers may submit a request for a RSR when they believe a GE plant is not subject to the regulation. APHIS reviews the GE plant and considers whether it might pose an increased plant pest risk compared to its non-GE comparator. If APHIS does not identify a greater pest risk relative to the comparator, the GE plant is not subject to this regulation. Regulation 7 CFR part 340 governs the importation, interstate movement, and the environmental release of certain organisms that have been modified or produced by genetic engineering.The USDA-APHIS review process is a critical component of ensuring that genetically engineered crops can be grown safely, and this approval opens the floor for expanded field trials, seed scaling, and eventual commercialization. With increasing interest in science-based ingredients, this approval positions the company to lead a new wave of innovation in the food and agriculture sectors.About Moolec Science SAMoolec is a science-based ingredient company leader in the use of Molecular Farming technology for food and dietary supplementation markets. The Company's mission is to create unique food ingredients by engineering plants with animal protein genes. Its purpose is to redefine the way the world produces animal proteins for the good of the planet. Moolec's technological approach aims to have the cost structure of plant-based solutions with the nutrition and functionality of animal-based ones. Moolec's technology has been under development for more than a decade and is known for pioneering the production of a bovine protein in a crop for the food industry. The Company's product portfolio and pipeline leverage the agronomic efficiency of broadly used target crops like soybean, pea, and safflower to produce oils and proteins. Moolec also has an industrial and commercial R&D capability to complement the company's Molecular Farming technology. Moolec secures a growing international patent portfolio (25+, both granted and pending) for its Molecular Farming technology. The Company is run by a diverse team of PhDs and Food Insiders, and operates in the United States, Europe, and South America. For more information, visit moolecscience.com and ir.moolecscience.com.Forward-Looking StatementsThis publication contains "forward-looking statements." Forward-looking statements may be identified by the use of words such as "forecast," "intend," "seek," "target," "anticipate," "believe," "expect," "estimate," "plan," "outlook," and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements with respect to performance, prospects, revenues, and other aspects of the business of Moolec are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Although we believe that we have a reasonable basis for each forward-looking statement contained in this publication, we caution you that these statements are based on a combination of facts and factors, about which we cannot be certain. We cannot assure you that the forward-looking statements in this publication will prove accurate. These forward-looking statements are subject to a number of significant risks and uncertainties that could cause actual results to differ materially from expected results, including, among others, changes in applicable laws or regulations, the possibility that Moolec may be adversely affected by economic, business and/or other competitive factors, costs related to the scaling up of Moolec's business and other risks and uncertainties, including those included under the header "Risk Factors" in Moolec's Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission ("SEC"), as well as Moolec's other filings with the SEC. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Accordingly, you should not put undue reliance on these statements.Contact InformationPress & Mediacomms@moolecscience.comInvestor Relationsir@moolecscience.comRelated FilesMoolec Has Received USDA Approval For The First Genetically Modified Pea In HistorySOURCE: Moolec Science Copyright 2024 ACN Newswire via SeaPRwire.com.